Novo Nordisk (NVON) Revenue
Novo Nordisk Revenue
Novo Nordisk had a revenue of 78.49B in the quarter ending Jun 30, 2026, with -18.94%. This bring the company's revenue in the last twelve months to 329.43B, Increased 0.50%. In the fiscal year ending Dec 31, 2025, Novo Nordisk had annual revenue of 309.06B with 6.43% growth.
- Revenue (ttm)
- 329.43B
- Revenue Growth
- 2.82%
- P/S Ratio
- 10.71
- Revenue/Employee
- MXN 4,492,601
- Employees
- 68,794
- Market Cap
- MXN 3.31T
Revenue Chart
Novo Nordisk Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 309.06B | 18.66B | 6.43% |
| Dec 31, 2024 | 290.40B | 58.14B | 25.03% |
| Dec 31, 2023 | 232.26B | 55.31B | 31.26% |
| Dec 31, 2022 | 176.95B | 36.15B | 25.68% |
| Dec 31, 2021 | 140.80B | 13.85B | 10.91% |
| Dec 31, 2020 | 126.95B | 4.92B | 4.04% |
| Dec 31, 2019 | 122.02B | 10.19B | 9.11% |
| Dec 31, 2018 | 111.83B | 135.00M | 0.12% |
| Dec 31, 2017 | 111.70B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.